Literature DB >> 16627216

Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings.

Shoichi Hishinuma1, Yoshiro Ogata, Moriaki Tomikawa, Iwao Ozawa, Kaoru Hirabayashi, Seiji Igarashi.   

Abstract

The autopsy findings of patients who died of recurrence after curative resection of pancreatic cancer may afford a reliable guide to increase long-term survival after surgery. Recurrence patterns were analyzed for 27 autopsied patients who had undergone potentially curative resection of pancreatic cancer. The pattern of recurrence was classified as follows: (1) local recurrence, (2) hepatic metastasis, (3) peritoneal dissemination, (4) para-aortic lymph node metastasis, and (5) distant metastasis not including hepatic metastasis, peritoneal dissemination, and para-aortic lymph node metastasis. Of the 27 autopsied patients, recurrence was confirmed for 22 of 24 patients, except for three who died of early postoperative complications. Eighteen (75%) of the 24 patients had local recurrence, 12 (50%) had hepatic metastasis, and 11 (46%) had both. For four patients, local recurrence confirmed by autopsy was undetectable by computed tomography, because the recurrent lesions had infiltrated without forming a tumor mass. Peritoneal dissemination, para-aortic lymph node metastasis, and distant metastasis were found for eight (33%), five (21%), and 18 (75%) of the cases, respectively. Twenty patients died of cancer, but local recurrence was judged to be the direct cause of death of only four. Local recurrence frequently occurs, but is rarely a direct cause of death, and most patients died of metastatic disease. Therefore, treatment that focuses on local control cannot improve the survival of patients with resectable pancreatic cancer, and thus, treatment regimens that are effective against systemic metastasis are needed.

Entities:  

Mesh:

Year:  2006        PMID: 16627216     DOI: 10.1016/j.gassur.2005.09.016

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  25 in total

1.  High-dose local irradiation plus prophylactic hepatic irradiation and chemotherapy for inoperable adenocarcinoma of the pancreas. A preliminary report of a multi-institutional trial (Radiation Therapy Oncology Group Protocol 8801).

Authors:  R Komaki; S Wadler; T Peters; R W Byhardt; S Order; M J Gallagher; A Herskovic; J Pederson
Journal:  Cancer       Date:  1992-06-01       Impact factor: 6.860

2.  Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group.

Authors:  J H Klinkenbijl; J Jeekel; T Sahmoud; R van Pel; M L Couvreur; C H Veenhof; J P Arnaud; D G Gonzalez; L T de Wit; A Hennipman; J Wils
Journal:  Ann Surg       Date:  1999-12       Impact factor: 12.969

3.  A randomized multicenter trial comparing resection and radiochemotherapy for resectable locally invasive pancreatic cancer.

Authors:  Masayuki Imamura; Ryuichiro Doi; Toshihide Imaizumi; Akihiro Funakoshi; Hideyuki Wakasugi; Makoto Sunamura; Yoshiro Ogata; Shoichi Hishinuma; Takehide Asano; Takashi Aikou; Ryo Hosotani; Shunzo Maetani
Journal:  Surgery       Date:  2004-11       Impact factor: 3.982

4.  Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience.

Authors:  Axel Richter; Marco Niedergethmann; Jörg W Sturm; Dietmar Lorenz; Stefan Post; Michael Trede
Journal:  World J Surg       Date:  2003-02-27       Impact factor: 3.352

5.  Pancreatic Cancer Registry in Japan: 20 years of experience.

Authors:  Seiki Matsuno; Shinichi Egawa; Shoji Fukuyama; Fuyuhiko Motoi; Makoto Sunamura; Shuji Isaji; Toshihide Imaizumi; Shuichi Okada; Hiroyuki Kato; Kouichi Suda; Akimasa Nakao; Takehisa Hiraoka; Ryo Hosotani; Kazunori Takeda
Journal:  Pancreas       Date:  2004-04       Impact factor: 3.327

6.  Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group.

Authors:  S Pedrazzoli; V DiCarlo; R Dionigi; F Mosca; P Pederzoli; C Pasquali; G Klöppel; K Dhaene; F Michelassi
Journal:  Ann Surg       Date:  1998-10       Impact factor: 12.969

7.  Regional pancreatectomy for cancer of the pancreas, ampulla, and other related sites. Tumor staging and results.

Authors:  J G Fortner
Journal:  Ann Surg       Date:  1984-04       Impact factor: 12.969

8.  Aggressive surgery for pancreatic duct cell cancer: feasibility, validity, limitations.

Authors:  S Takahashi; Y Ogata; H Miyazaki; D Maeda; S Murai; K Yamataka; T Tsuzuki
Journal:  World J Surg       Date:  1995 Jul-Aug       Impact factor: 3.352

9.  Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.

Authors:  Charles J Yeo; John L Cameron; Keith D Lillemoe; Taylor A Sohn; Kurtis A Campbell; Patricia K Sauter; JoAnn Coleman; Ross A Abrams; Ralph H Hruban
Journal:  Ann Surg       Date:  2002-09       Impact factor: 12.969

10.  Results of extensive surgery for pancreatic carcinoma.

Authors:  T Nagakawa; M Nagamori; F Futakami; Y Tsukioka; M Kayahara; T Ohta; K Ueno; I Miyazaki
Journal:  Cancer       Date:  1996-02-15       Impact factor: 6.860

View more
  101 in total

1.  Surveillance of pancreatic cancer patients after surgical resection.

Authors:  Kristin M Sheffield; Kristen T Crowell; Yu-Li Lin; Clarisse Djukom; James S Goodwin; Taylor S Riall
Journal:  Ann Surg Oncol       Date:  2011-12-06       Impact factor: 5.344

2.  Analysis of liver metastasis after resection for pancreatic ductal adenocarcinoma.

Authors:  Kwang Yeol Paik; Seong Ho Choi; Jin Seok Heo; Dong Wook Choi
Journal:  World J Gastrointest Oncol       Date:  2012-05-15

Review 3.  Biology and management of pancreatic cancer.

Authors:  Paula Ghaneh; Eithne Costello; John P Neoptolemos
Journal:  Gut       Date:  2007-08       Impact factor: 23.059

4.  Liver metastasis as an initial recurrence has no impact on the survival of patients with resectable pancreatic adenocarcinoma.

Authors:  Masaji Tani; Manabu Kawai; Motoki Miyazawa; Seiko Hirono; Shinomi Ina; Ryohei Nishioka; Yoichi Fujita; Kazuhisa Uchiyama; Hiroki Yamaue
Journal:  Langenbecks Arch Surg       Date:  2008-03-15       Impact factor: 3.445

Review 5.  Adjuvant radiotherapy for resected pancreatic cancer: a lack of benefit or a lack of adequate trials?

Authors:  Ruchika Gutt; Stanley L Liauw; Ralph R Weichselbaum
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2008-11-25

6.  Chronic stress accelerates pancreatic cancer growth and invasion: a critical role for beta-adrenergic signaling in the pancreatic microenvironment.

Authors:  Corina Kim-Fuchs; Caroline P Le; Matthew A Pimentel; David Shackleford; Davide Ferrari; Eliane Angst; Frédéric Hollande; Erica K Sloan
Journal:  Brain Behav Immun       Date:  2014-03-17       Impact factor: 7.217

7.  Identifying Clinical Factors Which Predict for Early Failure Patterns Following Resection for Pancreatic Adenocarcinoma in Patients Who Received Adjuvant Chemotherapy Without Chemoradiation.

Authors:  Steve Walston; Joseph Salloum; Carmine Grieco; Evan Wuthrick; Dayssy A Diaz; Christian Barney; Andrei Manilchuk; Carl Schmidt; Mary Dillhoff; Timothy M Pawlik; Terence M Williams
Journal:  Am J Clin Oncol       Date:  2018-12       Impact factor: 2.339

8.  Mortality after pancreaticoduodenectomy: assessing early and late causes of patient death.

Authors:  Sowmya Narayanan; Allison N Martin; Florence E Turrentine; Todd W Bauer; Reid B Adams; Victor M Zaydfudim
Journal:  J Surg Res       Date:  2018-06-27       Impact factor: 2.192

9.  Predictive risk factors for peritoneal recurrence after pancreatic cancer resection and strategies for its prevention.

Authors:  Kyohei Ariake; Fuyuhiko Motoi; Hideo Ohtsuka; Koji Fukase; Kunihiro Masuda; Masamichi Mizuma; Hiroki Hayashi; Kei Nakagawa; Takanori Morikawa; Shimpei Maeda; Tatsuyuki Takadate; Takeshi Naitoh; Shinichi Egawa; Michiaki Unno
Journal:  Surg Today       Date:  2017-04-22       Impact factor: 2.549

10.  Impact of preoperative therapy on patterns of recurrence in pancreatic cancer.

Authors:  Pavlos Papavasiliou; John P Hoffman; Steven J Cohen; Joshua E Meyer; James C Watson; Yun Shin Chun
Journal:  HPB (Oxford)       Date:  2013-02-20       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.